Clinical Trial Update: Epicardial Infarct Repair Using CorMatrix®-ECM: Clinical Feasibility Study [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of an early-phase feasibility study evaluating epicardial infarct repair using CorMatrix-ECM in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Heart Failure

Drugs mentioned

• CorMatrix ECM

Snippet

Sponsor: University of Calgary | Conditions: Acute Coronary Syndrome, Heart Failure | EARLY_Phase 1 | Status: COMPLETED